VSee Health, Inc. Cost of Revenue
VSee Health, Inc. (VSEE) reported Cost of Revenue of $1.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-14
- VSee Health, Inc. cost of revenue for the quarter ending 2026-06-30 was $1.36M, a 208.02% increase year-over-year.
- VSee Health, Inc. cost of revenue for the quarter ending 2026-03-31 was $1.96M, a 34.25% increase year-over-year.
- VSee Health, Inc. cost of revenue for the quarter ending 2025-12-31 was $2.09M, a 54.57% increase year-over-year.
- VSee Health, Inc. cost of revenue for the quarter ending 2025-09-30 was $1.91M, a 234.78% increase year-over-year.
- VSee Health, Inc. cost of revenue for fiscal 2025 was $7.26M, a 123.88% increase from fiscal 2024.
- VSee Health, Inc. cost of revenue for fiscal 2024 was $3.24M, a 67.79% increase from fiscal 2023.
- VSee Health, Inc. cost of revenue for fiscal 2023 was $1.93M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.36M 10-Q · filed 2026-08-14 | $2.51M 10-Q · filed 2026-08-14 | $5.41M derived: sum of 3 quarters · filed 2026-08-14 | $7.32M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $1.96M 10-Q · filed 2026-05-15 | $4.05M derived: sum of 2 quarters · filed 2026-05-15 | $5.96M derived: sum of 3 quarters · filed 2026-05-15 | $6.40M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.00M derived: sum of 2 quarters · filed 2026-03-31 | $4.44M derived: sum of 3 quarters · filed 2026-08-14 | $7.26M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $1.91M 10-Q · filed 2025-11-14 | $2.35M derived: sum of 2 quarters · filed 2026-08-14 | $5.17M 10-Q · filed 2025-11-14 | $5.16M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $440.15K 10-Q · filed 2026-08-14 | $1.80M 10-Q · filed 2025-10-15 | $827.52K 10-Q · filed 2026-08-14 | $3.26M 10-Q · filed 2025-10-15 | $3.25M derived: sum of 3 quarters · filed 2026-08-14 | $3.82M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.46M 10-Q · filed 2026-05-15 | $2.81M derived: sum of 2 quarters · filed 2026-05-15 | $3.38M derived: sum of 3 quarters · filed 2026-05-15 | $4.32M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.92M derived: sum of 2 quarters · filed 2026-03-31 | $2.86M derived: sum of 3 quarters · filed 2026-03-31 | $3.24M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $569.73K 10-Q · filed 2025-11-14 | $1.50M derived: sum of 2 quarters · filed 2025-11-20 | $1.89M 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $934.57K 10-Q/A · filed 2025-11-20 | $1.32M 10-Q/A · filed 2025-11-20 | ||||
| 2024-03-31 | $386.25K 10-Q · filed 2025-10-15 | |||||
| 2023-12-31 | $1.93M 10-K/A · filed 2025-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |